These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21458664)

  • 1. The evolving war on cancer.
    Haber DA; Gray NS; Baselga J
    Cell; 2011 Apr; 145(1):19-24. PubMed ID: 21458664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Clinical Trials: The Rear-View Mirror and the Crystal Ball.
    Cescon D; Siu LL
    Cell; 2017 Feb; 168(4):575-578. PubMed ID: 28187280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The war on cancer: have we won the battle but lost the war?
    Brennan R; Federico S; Dyer MA
    Oncotarget; 2010 Jun; 1(2):77-83. PubMed ID: 20877440
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
    Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA
    Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.
    Chen X; Guo Y; Chen X
    Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):150-160. PubMed ID: 32916316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researching the cost of research.
    Wright JR; Levine MN
    J Clin Oncol; 2003 Nov; 21(22):4081-2. PubMed ID: 14559890
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-drug conjugates for cancer: poised to deliver?
    Hughes B
    Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367
    [No Abstract]   [Full Text] [Related]  

  • 9. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE
    Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspective on the application of pharmacogenomics in the treatment of cancer.
    Wolf R
    Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent Advances and Perspectives in Cancer Drug Design.
    Magalhaes LG; Ferreira LLG; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 2):1233-1250. PubMed ID: 29768576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.
    Youssoufian H
    IDrugs; 2010 Dec; 13(12):833-5. PubMed ID: 21154137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical cancer research 2001: new agents and therapies.
    Verweij J; de Vries EG
    Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery.
    Kostic M; Arkin M
    Cell Chem Biol; 2017 Sep; 24(9):1057. PubMed ID: 28938086
    [No Abstract]   [Full Text] [Related]  

  • 16. From silos to a critical path of new agent development: a paradigm to revolutionize clinical research.
    Benson AB
    J Clin Oncol; 2008 Apr; 26(12):1924-5. PubMed ID: 18421045
    [No Abstract]   [Full Text] [Related]  

  • 17. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
    Brockmoeller J; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Organic Synthesis in the Emergence and Development of Antibody-Drug Conjugates as Targeted Cancer Therapies.
    Nicolaou KC; Rigol S
    Angew Chem Int Ed Engl; 2019 Aug; 58(33):11206-11241. PubMed ID: 31012193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases.
    Stewart DJ; Batist G; Kantarjian HM; Bradford JP; Schiller JH; Kurzrock R
    Clin Cancer Res; 2015 Oct; 21(20):4561-8. PubMed ID: 26473192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke.
    Edwards G
    Drug Discov Today; 2005 Nov; 10(22):1491-4. PubMed ID: 16257369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.